nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—ulcerative colitis	0.366	0.53	CbGaD
Clenbuterol—ADRB2—ulcerative colitis	0.325	0.47	CbGaD
Clenbuterol—CYP1A1—Nicotine—ulcerative colitis	0.0657	0.366	CbGbCtD
Clenbuterol—CYP1A1—Cholecalciferol—ulcerative colitis	0.059	0.328	CbGbCtD
Clenbuterol—CYP1A2—Nicotine—ulcerative colitis	0.0294	0.164	CbGbCtD
Clenbuterol—CYP1A1—Dexamethasone—ulcerative colitis	0.0255	0.142	CbGbCtD
Clenbuterol—Bambuterol—ADRB2—ulcerative colitis	0.00175	0.301	CrCbGaD
Clenbuterol—Pirbuterol—ADRB2—ulcerative colitis	0.00133	0.228	CrCbGaD
Clenbuterol—Terbutaline—ADRB2—ulcerative colitis	0.00108	0.186	CrCbGaD
Clenbuterol—Bupranolol—ADRB2—ulcerative colitis	0.000855	0.147	CrCbGaD
Clenbuterol—Salbutamol—ADRB2—ulcerative colitis	0.000804	0.138	CrCbGaD
Clenbuterol—NGF—Signaling Pathways—CCR6—ulcerative colitis	7.57e-05	0.000613	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—ulcerative colitis	7.51e-05	0.000608	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	7.5e-05	0.000607	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNA12—ulcerative colitis	7.44e-05	0.000602	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—ulcerative colitis	7.36e-05	0.000596	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR6—ulcerative colitis	7.3e-05	0.000591	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	7.3e-05	0.000591	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAML2—ulcerative colitis	7.17e-05	0.000581	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—ulcerative colitis	7.1e-05	0.000575	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL1B—ulcerative colitis	7.06e-05	0.000572	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR2—ulcerative colitis	7.05e-05	0.000571	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	6.81e-05	0.000552	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	6.81e-05	0.000552	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—ulcerative colitis	6.76e-05	0.000547	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	6.75e-05	0.000546	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	6.72e-05	0.000544	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	6.71e-05	0.000544	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	6.71e-05	0.000543	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTGER4—ulcerative colitis	6.66e-05	0.000539	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR6—ulcerative colitis	6.63e-05	0.000537	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	6.62e-05	0.000536	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	6.6e-05	0.000534	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—ulcerative colitis	6.59e-05	0.000533	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SEL1L—ulcerative colitis	6.46e-05	0.000523	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	6.44e-05	0.000521	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	6.44e-05	0.000521	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PTGER4—ulcerative colitis	6.43e-05	0.00052	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	6.39e-05	0.000517	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—ulcerative colitis	6.38e-05	0.000516	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—ulcerative colitis	6.26e-05	0.000507	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	6.25e-05	0.000506	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—STAT3—ulcerative colitis	6.25e-05	0.000506	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	6.18e-05	0.0005	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GHRL—ulcerative colitis	6.1e-05	0.000494	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—ulcerative colitis	6.07e-05	0.000491	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	6.04e-05	0.000489	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.02e-05	0.000487	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	6.01e-05	0.000486	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	5.99e-05	0.000485	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	5.97e-05	0.000483	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—ulcerative colitis	5.96e-05	0.000483	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CALM3—ulcerative colitis	5.91e-05	0.000478	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	5.89e-05	0.000477	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	5.89e-05	0.000477	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GHRL—ulcerative colitis	5.88e-05	0.000476	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	5.85e-05	0.000473	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PTGER4—ulcerative colitis	5.84e-05	0.000472	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RIPK2—ulcerative colitis	5.82e-05	0.000471	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—ulcerative colitis	5.79e-05	0.000469	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	5.76e-05	0.000466	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—ulcerative colitis	5.75e-05	0.000466	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NFKB1—ulcerative colitis	5.66e-05	0.000458	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	5.59e-05	0.000452	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.47e-05	0.000442	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	5.35e-05	0.000433	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GHRL—ulcerative colitis	5.34e-05	0.000433	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR1—ulcerative colitis	5.32e-05	0.000431	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—ulcerative colitis	5.3e-05	0.000429	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	5.23e-05	0.000423	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CALM3—ulcerative colitis	5.17e-05	0.000419	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	5.17e-05	0.000419	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—ulcerative colitis	5.15e-05	0.000417	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	5.11e-05	0.000414	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	5.11e-05	0.000414	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	5.06e-05	0.000409	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADRB2—ulcerative colitis	5.05e-05	0.000409	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADRB2—ulcerative colitis	4.87e-05	0.000394	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	4.86e-05	0.000393	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	4.75e-05	0.000385	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—ulcerative colitis	4.72e-05	0.000382	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—ulcerative colitis	4.72e-05	0.000382	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	4.69e-05	0.00038	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL20—ulcerative colitis	4.67e-05	0.000378	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	4.65e-05	0.000377	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	4.61e-05	0.000373	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	4.59e-05	0.000372	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	4.51e-05	0.000365	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRB2—ulcerative colitis	4.42e-05	0.000358	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	4.41e-05	0.000357	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNA12—ulcerative colitis	4.39e-05	0.000356	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—ulcerative colitis	4.36e-05	0.000353	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	4.35e-05	0.000352	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	4.35e-05	0.000352	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	4.33e-05	0.000351	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	4.32e-05	0.00035	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	4.31e-05	0.000349	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADCY5—ulcerative colitis	4.29e-05	0.000347	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.26e-05	0.000345	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	4.24e-05	0.000343	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	4.18e-05	0.000339	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR2—ulcerative colitis	4.16e-05	0.000337	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—ulcerative colitis	4.16e-05	0.000337	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—ulcerative colitis	4.14e-05	0.000335	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	4.14e-05	0.000335	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADCY5—ulcerative colitis	4.13e-05	0.000335	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	4.09e-05	0.000331	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	3.93e-05	0.000318	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR6—ulcerative colitis	3.92e-05	0.000317	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—ulcerative colitis	3.88e-05	0.000314	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	3.85e-05	0.000312	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	3.84e-05	0.000311	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	3.81e-05	0.000309	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.77e-05	0.000305	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CHP1—ulcerative colitis	3.76e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADCY5—ulcerative colitis	3.75e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	3.75e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	3.73e-05	0.000302	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAML2—ulcerative colitis	3.71e-05	0.0003	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.52e-05	0.000285	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.5e-05	0.000284	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PPARG—ulcerative colitis	3.5e-05	0.000283	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	3.49e-05	0.000283	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	3.46e-05	0.00028	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTGER4—ulcerative colitis	3.45e-05	0.000279	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	3.42e-05	0.000277	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	3.39e-05	0.000274	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DLD—ulcerative colitis	3.24e-05	0.000263	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.24e-05	0.000263	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.17e-05	0.000257	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	3.17e-05	0.000257	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	3.16e-05	0.000256	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GHRL—ulcerative colitis	3.16e-05	0.000255	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	3.1e-05	0.000251	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	3.09e-05	0.00025	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	3.07e-05	0.000249	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CALM3—ulcerative colitis	3.06e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RIPK2—ulcerative colitis	3.01e-05	0.000244	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	3e-05	0.000243	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—JAK2—ulcerative colitis	2.93e-05	0.000237	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.89e-05	0.000234	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—RELA—ulcerative colitis	2.83e-05	0.000229	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	2.77e-05	0.000225	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	2.71e-05	0.00022	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JAK2—ulcerative colitis	2.67e-05	0.000216	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	2.62e-05	0.000212	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB2—ulcerative colitis	2.61e-05	0.000211	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	2.61e-05	0.000211	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RELA—ulcerative colitis	2.59e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—JAK2—ulcerative colitis	2.58e-05	0.000209	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	2.55e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	2.47e-05	0.0002	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	2.47e-05	0.0002	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.45e-05	0.000199	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—ulcerative colitis	2.44e-05	0.000197	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	2.42e-05	0.000196	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	2.42e-05	0.000196	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—ulcerative colitis	2.41e-05	0.000196	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	2.4e-05	0.000194	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.4e-05	0.000194	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NFKB1—ulcerative colitis	2.39e-05	0.000193	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—ulcerative colitis	2.35e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—JAK2—ulcerative colitis	2.34e-05	0.000189	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—ulcerative colitis	2.33e-05	0.000189	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	2.32e-05	0.000188	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	2.27e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—ulcerative colitis	2.25e-05	0.000182	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.25e-05	0.000182	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	2.23e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADCY5—ulcerative colitis	2.22e-05	0.00018	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—ulcerative colitis	2.21e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	2.2e-05	0.000178	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NFKB1—ulcerative colitis	2.18e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	2.18e-05	0.000176	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	2.16e-05	0.000174	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—STAT3—ulcerative colitis	2.15e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	2.14e-05	0.000173	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DLD—ulcerative colitis	2.07e-05	0.000167	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	2.05e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	2.04e-05	0.000165	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	2e-05	0.000162	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—ulcerative colitis	1.99e-05	0.000161	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—ulcerative colitis	1.96e-05	0.000159	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	1.87e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	1.83e-05	0.000148	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—ulcerative colitis	1.82e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	1.79e-05	0.000145	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	1.77e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	1.75e-05	0.000142	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.72e-05	0.000139	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS1—ulcerative colitis	1.57e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	1.55e-05	0.000126	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.54e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	1.53e-05	0.000124	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—ulcerative colitis	1.5e-05	0.000121	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—ulcerative colitis	1.5e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	1.5e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CALM3—ulcerative colitis	1.41e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.4e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	1.39e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	1.38e-05	0.000112	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—ulcerative colitis	1.37e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.37e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	1.36e-05	0.00011	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.35e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RELA—ulcerative colitis	1.34e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	1.33e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	1.32e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	1.31e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	1.29e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	1.27e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	1.26e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	1.24e-05	0.0001	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	1.21e-05	9.81e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—ulcerative colitis	1.21e-05	9.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	1.2e-05	9.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	1.19e-05	9.59e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	1.14e-05	9.24e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	1.13e-05	9.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCB1—ulcerative colitis	1.1e-05	8.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.09e-05	8.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADCY5—ulcerative colitis	1.02e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	1.01e-05	8.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1e-05	8.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.84e-06	7.96e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	9.41e-06	7.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CALM3—ulcerative colitis	9e-06	7.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.6e-06	6.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	8.2e-06	6.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	8.03e-06	6.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	7.95e-06	6.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	7.77e-06	6.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—ulcerative colitis	7.74e-06	6.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—ulcerative colitis	7.64e-06	6.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	7.49e-06	6.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	7.33e-06	5.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	7.16e-06	5.79e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	7.12e-06	5.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—ulcerative colitis	7.09e-06	5.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCB1—ulcerative colitis	7e-06	5.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	7e-06	5.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	6.97e-06	5.64e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—ulcerative colitis	6.87e-06	5.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	6.77e-06	5.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	6.7e-06	5.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	6.63e-06	5.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	6.56e-06	5.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADCY5—ulcerative colitis	6.53e-06	5.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	6.02e-06	4.88e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—ulcerative colitis	6.01e-06	4.87e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	5.89e-06	4.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	5.58e-06	4.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	5.46e-06	4.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.87e-06	3.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	4.6e-06	3.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	4.5e-06	3.64e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—ulcerative colitis	4.38e-06	3.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	4.21e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	4.11e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.83e-06	3.1e-05	CbGpPWpGaD
